The Aperlena Verdict
Open raceNo supplier dominates: 130 different companies have won the last 293 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- -60.1%
- Expected final price vs the published estimate
Based on 293 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryA Czech public tender for repeated deliveries of medicinal products containing interferon beta-1a, which must meet the requirements of the State Institute for Drug Control (SUKL). The buyer is a Czech contracting authority, with deliveries to the Czech Republic. The procurement concerns recurring supplies of medicines under an ongoing framework arrangement. No estimated contract value or submission deadline is stated in the available notice. The procedure is a public procurement open to suppliers able to meet the specified requirements for these medicinal products. Interested economic operators should consult the full tender documents for detailed conditions and participation rules.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago
More from this buyer
Full buyer profile40 open tenders right now
- Česko - Antineoplastika a imunomodulátory - LP s obsahem enkorafenibu II. 2026 1 day left
- Česko - Endoskopie, endochirurgické přístroje - Systém pro endosonografii II. 4 days left
- Česko - Kontejnery na odpadový materiál - Nádoby na kontaminovaný odpad 4 days left
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Alliance Healthcare s.r.o. | 28 | €17.6M | Aug 2026 |
| PHOENIX lékárenský velkoobchod, s.r.o. | 26 | €17.9M | Aug 2026 |
| PHARMOS, a.s. | 12 | €4.9M | Jun 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 11 | €3.9M | Aug 2026 |
| Boston Scientific Česká republika s.r.o. | 10 | €3.5M | Aug 2026 |
Based on 293 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 296 comparable contracts this buyer awarded in this sector over the last 4 years.
- €83,692
- Lower quartile
- €181,723
- Median award
- €585,895
- Upper quartile
This tender is estimated 289.4% above that median
Most recent awards
- Česko - Oftalmologika - Fluoruracil I.V. 2026 €135,148
- Česko - Léčivé přípravky a zdravotnické prostředky - Dynamický nákupní systém na dodávky léčivých přípravků €291,716
- Česko - Imunosupresiva - LP s obsahem certolizumab pegolu 2026 €528,750
- Česko - Analgetika - LP s obsahem eptinezumabu 2026 €308,565
- Česko - Imunosupresiva - LP s obsahem karfilzomibu 2026 €1,996,069
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€18,767
est. value
1
day left
€166,877
est. value
1
day left
€2,913,230
est. value
1
day left
€372,555
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €9,466,835
- Buyer track record on Aperlena
- 743 notices tracked · 391 awarded
- €528,953,604 in awarded contracts
Never miss a tender like this
136 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert